CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 4 Open-market sale Director sold 15,827 shares at $18.90 ($299,110)
- 4 Open-market sale EVP Corp Admin Center sold 14,592 shares at an average $19.14 ($279,339)
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Acquisition or sale completed · Executive or director change · Regulation FD disclosure
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 34,131 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Corp Admin Center gave up 2,430 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Production Center gave up 3,303 shares (to pay taxes)
- 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 6,398 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Corp Admin Center gave up 1,559 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Production Center gave up 1,652 shares (to pay taxes)
- 4 Open-market sale CFO, SVP & Treasurer sold 4,244 shares at $19.03 ($80,745)
- 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 37,680 shares (to pay taxes)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale CEO & Chief Scientific Officer sold 30,467 shares at an average $18.59 ($566,315)
Page 23 of 48 · 958 filings